Agilon Health (AGL) Enterprise Value (2020 - 2026)

Agilon Health has reported Enterprise Value for 7 years, with the latest figure at -$231.4 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 36.96% year-over-year to -$231.4 million; the trailing twelve-month figure through Mar 2026 stood at -$231.4 million (up 36.96% YoY), and the FY2025 full-year result was -$285.1 million, up 28.71% from the prior year.
• Enterprise Value for Q1 2026 stood at -$231.4 million, up from -$285.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$231.4 million in Q1 2026, with the low at -$1.0 billion in Q1 2022.
• Historically, Enterprise Value has averaged -$553.1 million across 5 years, with a median of -$419.9 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value tumbled 870.11% — and 2024, when it soared 48.63%.
• Agilon Health's Enterprise Value stood at -$877.8 million in 2022, then surged by 44.28% to -$489.2 million in 2023, then rose by 18.23% to -$400.0 million in 2024, then gained by 28.71% to -$285.1 million in 2025, then grew by 18.84% to -$231.4 million in 2026.
• The last three Enterprise Value figures came in at -$231.4 million (Q1 2026), -$285.1 million (Q4 2025), and -$310.9 million (Q3 2025), per Business Quant data.